SOCS2, suppressor of cytokine signaling 2, 8835

N. diseases: 104; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.050 AlteredExpression disease BEFREE MiR-492 exerts tumor-promoting function in prostate cancer through repressing SOCS2 expression. 30779065 2019
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.050 Biomarker disease BEFREE Conversely, inhibition of miR-194 activity suppressed the invasive capacity of prostate cancer cell lines <i>in vitro</i> and <i>in vivo</i> Mechanistic investigations identified the ubiquitin ligase suppressor of cytokine signaling 2 (SOCS2) as a direct, biologically relevant target of miR-194 in prostate cancer. 28011622 2017
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.050 AlteredExpression disease BEFREE In addition, we proved that SOCS2 expression is significantly elevated upon androgenic stimulation in androgen receptor (AR)-positive cell lines, providing a possible mechanistic explanation for high SOCS2 levels in PCa tissue. 24280133 2014
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.050 AlteredExpression disease BEFREE Androgen induced SOCS2 ubiquitin ligase expression and inhibited GH signaling as well as cell proliferation and invasion in PCa, whereas reduced SOCS2 was present in castration-resistant cases. 24031028 2014
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.050 Biomarker disease BEFREE Our data offer the convincing evidence for the first time that the dysregulation of SOCS2 and SOCS6 may be associated with the aggressive progression of PCa. 23666742 2013